These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24044994)

  • 1. A polyvalent aptamer system for targeted drug delivery.
    Zhang Z; Ali MM; Eckert MA; Kang DK; Chen YY; Sender LS; Fruman DA; Zhao W
    Biomaterials; 2013 Dec; 34(37):9728-35. PubMed ID: 24044994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
    Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
    J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.
    Pi F; Zhang H; Li H; Thiviyanathan V; Gorenstein DG; Sood AK; Guo P
    Nanomedicine; 2017 Apr; 13(3):1183-1193. PubMed ID: 27890659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembled aptamer-based drug carriers for bispecific cytotoxicity to cancer cells.
    Zhu G; Meng L; Ye M; Yang L; Sefah K; O'Donoghue MB; Chen Y; Xiong X; Huang J; Song E; Tan W
    Chem Asian J; 2012 Jun; 7(7):1630-6. PubMed ID: 22492537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
    Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
    Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery.
    Zhang H; Ma Y; Xie Y; An Y; Huang Y; Zhu Z; Yang CJ
    Sci Rep; 2015 May; 5():10099. PubMed ID: 25959874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of doxorubicin using a colorectal cancer-specific ssDNA aptamer.
    Li W; Chen H; Yu M; Fang J
    Anat Rec (Hoboken); 2014 Dec; 297(12):2280-8. PubMed ID: 25044297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration.
    Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S
    Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
    Taghdisi SM; Lavaee P; Ramezani M; Abnous K
    Eur J Pharm Biopharm; 2011 Feb; 77(2):200-6. PubMed ID: 21168488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer.
    Bayrac AT; Akca OE; Eyidogan FI; Oktem HA
    J Biosci; 2018 Mar; 43(1):97-104. PubMed ID: 29485118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
    Luo YL; Shiao YS; Huang YF
    ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy.
    Chang M; Yang CS; Huang DM
    ACS Nano; 2011 Aug; 5(8):6156-63. PubMed ID: 21732610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.
    He X; Hai L; Su J; Wang K; Wu X
    Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells.
    Li Y; Lei Y; Wagner E; Xie C; Lu W; Zhu J; Shen J; Wang J; Liu M
    Bioconjug Chem; 2013 Jan; 24(1):133-43. PubMed ID: 23241015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-drug conjugation for targeted tumor cell therapy.
    Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
    Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer.
    Taghdisi SM; Abnous K; Mosaffa F; Behravan J
    J Drug Target; 2010 May; 18(4):277-81. PubMed ID: 19943768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.
    Kim E; Jung Y; Choi H; Yang J; Suh JS; Huh YM; Kim K; Haam S
    Biomaterials; 2010 Jun; 31(16):4592-9. PubMed ID: 20206379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer.
    Subramanian N; Raghunathan V; Kanwar JR; Kanwar RK; Elchuri SV; Khetan V; Krishnakumar S
    Mol Vis; 2012; 18():2783-95. PubMed ID: 23213278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
    Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
    Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.